bacteria bound or accumulated approximately 5 x 104 molecules of ramoplanin per cell, only 1/100th of the amount of vancomycin which binds to groups within peptidoglycan conforming to the pattern L-aa (amino acid)-D-aa-D-aa, suggesting that ramoplanin has a different target site. This was confirmed by in vitro studies involving a wall-membrane particulate fraction from Gaffy homari in which peptidoglycan synthesis from UDP-MurNAc-tetrapeptide was inhibited by ramoplanin but not by vancomycin. The incorporation of peptidoglycan precursors into nascent peptidoglycan of a toluenized cell preparation of B. megaterium was inhibited by ramoplanin, indicating that the antibiotic acts at a step before transpeptidation. In vitro studies of a wall-membrane particulate fraction of B. megaterium indicated that ramoplanin did not prevent the formation of lipid intermediate I (undecaprenyl-P-P-MurNAc-pentapeptide) but inhibited the next reaction in which N-acetylglucosamine is transferred to that lipid intermediate. The high concentrations required to inhibit in vitro peptidoglycan-synthesizing systems probably reflect the high concentrations of target sites present. High concentrations of ramoplanin also damage certain properties of the cell membrane, but low concentrations only affected wall synthesis in intact bacteria without perturbing membrane function. These studies indicate that the primary target of ramoplanin is peptidoglycan biosynthesis and that the probable reaction inhibited is the N-acetylglucosaminyltransferase-catalyzed conversion of lipid intermediate I to lipid intermediate II. Several selectively active antibiotics have been shown to inhibit cell wall peptidoglycan biosynthesis, including the ,B-lactams (12) , the glycopeptides (16) , and more recently a lipoglycopeptide, daptomycin (LY146032) (2) . The increased incidence of resistance to some of these antibiotics (6, 24) has serious clinical consequences and indicates the importance of evaluation of new antibiotics for the treatment of gram-positive infections.
Ramoplanin is a new lipoglycopeptide antibiotic produced from an Actinoplanes strain (4) . It is a complex of three components, designated Al, A2, and A3. The three factors have a common cyclic peptide part composed of 17 amino acids and a dimannosyl unit and differ in the nature of the diunsaturated fatty acid chain ( Fig. 1) (11) . Ramoplanin inhibits cell wall peptidoglycan biosynthesis without affecting other macromolecular syntheses (4) . In this study, the mechanism by which ramoplanin interferes with this process is investigated.
MATERIALS AND METHODS
Bacteria and growth conditions. The organisms used in these investigations were Staphylococcus aureus, Bacillus megaterium KM, and Gafflya homari. Unless otherwise stated, they were grown in a complex medium containing (wtlvol) 1% tryptone, 0.5% yeast extract, 0.25% K2HPO4, * Corresponding author. and 0.5% glucose (pH 7.2) (TYE medium) at 37°C with shaking. Growth was observed by monitoring the bacterial density at 600 nm (A6w).
Accumulation and identification of nucleotide-linked peptidoglycan precursor in antibiotic-treated cells. S. aureus and B. megaterium were grown in CPYE medium (19) to the mid-log phase at 37°C with shaking. Aliquots (100 ml) were incubated with various concentrations of ramoplanin for 30 min at 37°C, harvested, washed with 10 mM phosphate buffer (pH 7.0), and extracted twice with 5% trichloroacetic acid (TCA) at 4°C (1.5 ml). Extracts were analyzed for nucleotides containing N-acetylhexosamines by the method of Reissig et al. (15) . Purification 25°C. Duplicate samples were treated with 1 ml of 5% (wt/vol) TCA either at 4°C for 10 min or at 4°C for 10 min followed by treatment with 4% (wt/vol) sodium dodecyl sulfate (SDS) at 95°C for 20 min. The samples were filtered, and insoluble material was collected, dried, and counted.
Preparation of particulate fractions. Cell-free particulate fractions catalyzing the polymerization of peptidoglycan from UDP-linked precursors were isolated from B. megaterium and G. homari by the methods of Reynolds (18) Loss of UV-absorbing components and intracellular potassium. The effect of antibiotics on membrane integrity and function in S. aureus was measured by observing the release of UV-absorbing components and of intracellular potassium. Bacteria (1 mg [dry weight] per ml) were suspended in 50 mM Tris hydrochloride (pH 8) and incubated with various concentrations of ramoplanin for 20 min at 37°C. Release of UV-absorbing material and intracellular potassium into the medium was measured at 260 nm with a Cary 118 spectrophotometer and a Perkin-Elmer 380 atomic absorption spectrophotometer, respectively.
Uptake of a-methylglucoside. Uptake of a-methylglucoside by S. aureus growing exponentially in a synthetic growth medium (1) was measured essentially as described previously (2) .
RESULTS
Accumulation of UDP-MurNAc-pentapeptide in S. aureus. Accumulation of hexosamine-containing nucleotides in S. aureus in the presence of ramoplanin occurred at concentrations of the antibiotic close to the MIC, between 0.3 and 1 ,ug/ml (Fig. 2) . Purification and identification of the precursor that accumulated in S. aureus indicated that it was UDPMurNAc-pentapeptide, the same nucleotide that accumulated when staphylococci were incubated with penicillin (12, 13) or vancomycin (16) . This finding indicates that ramoplanin inhibits a later step in peptidoglycan biosynthesis, after formation of the cytoplasmic precursor UDP-MurNAc-pentapeptide.
Binding studies. Centrifugation rather than filtration was used to remove bacteria before bioassay because ramoplanin bound to the filters. In control experiments, its concentration in solution before and after centrifugation was the same, and it did not bind nonspecifically to the tubes. Conditions for the bioassay were chosen so that residual concentrations of ramoplanin could be determined to an accuracy of ±+25%; this required investigation of the effect of ramoplanin on the rate of growth of B. megaterium as opposed to reliance on a single overnight time point. Concentrations of bacteria and ramoplanin were selected to give a substantial percentage change in the concentration of the antibiotic. A total of 50% of the ramoplanin was removed from solution after incubation of S. aureus (0.5 mg/ml; 2 x 109 cells per ml) with the antibiotic at the MIC (1 ,ug/ml). At higher concentrations of both S. aureus (2.5 mg/ml; 1 x 1010 cells per ml) and ramoplanin (10 ,ug/ml), approximately 30% was removed from solution. Therefore, substantial amounts of ramoplanin were either bound to the outer layers of the bacteria or had been taken up into the cytoplasm; the amount removed from solution corresponded to approximately 5 x 104 molecules per cell. This is a much lower value than for vancomycin (107 molecules per cell [17] ). Similar amounts of ramoplanin were removed at both 0 and 25°C in buffer or in growth medium, suggesting that binding rather than transport was being studied; furthermore, binding occurred rapidly since bacteria treated with ramoplanin (10 pug/ml) for 30 s followed by centrifugation and washing accumulated cell wall precursors during a further 30-min incubation in growth medium lacking the antibiotic, even though no obvious effect on actual growth (turbidity) was evident during that incubation period. This suggests that the binding of ramoplanin is sufficiently strong to resist washing and that bound antibiotic had a residual effect on peptidoglycan biosynthesis.
Effects on membrane-associated peptidoglycan-synthesizing enzymes. Further indication that ramoplanin has a mechanism of action distinct from that of the glycopeptides was provided by studies with a cell-free system from G. homari. The particulate fraction from this organism is able to utilize not only the pentapeptide but the tetrapeptide derivative of UDP-MurNAc and catalyzes the transfer of MurNAc-tetrapeptide to the lipid carrier and the synthesis of glycan chains. As expected, this reaction was unaffected by vancomycin, even at high concentrations (100 ,u.g/ml). In contrast, ramoplanin inhibited the incorporation of both radiolabeled substrates into polymerized peptidoglycan (Table 1) .
To elucidate the enzymatic reaction inhibited by ramoplanin, we investigated the individual reactions catalyzed by membrane-bound enzymes, both in toluenized bacteria in which polymerization of wall subunits to form nascent peptidoglycan and transpeptidation which links nascent to existing peptidoglycan can be distinguished and in wallmembrane preparations in which synthesis of the lipid intermediates can be observed in addition to the polymerization reaction (3, 10) . Polymerization of UDP-linked sugar precursors by a toluenized preparation of B. megaterium was inhibited by ramoplanin ( Table 2 ). Almost complete inhibition of labeled UDP-GlcNAc incorporation into both the TCA-precipitable fraction and the SDS-precipitable fraction was observed at high concentrations (100 ,ug/ml), although substantial inhibition also occurred at lower concentrations (10 jig/ml). In the control incubation, similar amounts of substrate were incorporated into the SDS-and TCA-precipitable fractions, indicating that nascent peptidoglycan was linked covalently to existing wall almost concomitantly with its synthesis. When cloxacillin (1 ,ug/ml) was present, crosslinking to the existing wall was completely inhibited ( (Fig. 3) . Incorporation into lipid intermediate II was inhibited when ramoplanin was present (Table 5) , but moenomycin and daptomycin were without effect (Fig. 3) . As expected, moenomycin and vancomycin prevented subsequent utilization of lipid intermediate II. To obtain measurable activities, we did these partial reaction studies with high concentrations of membrane protein (10 mg/ml) corresponding to 100 mg of bacteria per ml. Under these circumstances, the concentration of target sites is increased enormously compared with the situation existing under conditions in which MICs were measured; consequently, it is not surprising that high concentrations of ramoplanin (30 to 100 ,g/ml) were required to obtain inhibition in excess of 75%.
Effects on membrane function. The studies on accumulation of cytoplasmic precursors showed that the effects of ramoplanin occurred at the MIC for S. aureus, indicating that the primary target site is likely to be peptidoglycan biosynthesis. However, the in vitro systems in which wall precursors were polymerized to form peptidoglycan were inhibited substantially only at much higher concentrations of ramoplanin (30 to 100 ,ug/ml). Therefore, we did a series of experiments to investigate the effects of high and low concentrations of ramoplanin on general membrane disorganization. At high concentrations, ramoplanin (100 ,ug/ml) induced leakage of both potassium and UV-absorbing material from S. aureus, although no leakage was apparent at con- centrations up to 10-fold greater than the MIC (Fig. 4) . Ramoplanin also had little inhibitory effect on uptake of a-methylglucoside until its concentration had been raised to 30 ,ug/ml, even though the bacteria were present at low densities. In addition to these experiments, studies involving protoplasts were done to investigate the possibility of additional target sites for ramoplanin other than the cell wall. Lysis of stabilized protoplasts of B. megaterium did not occur until high concentrations of ramoplanin (100 times the MIC) were added. Similarly, inhibition of macromolecular biosynthesis in protoplasts was only observed at high concentrations (data not shown).
DISCUSSION
Inhibition of the growth of S. aureus and B. megaterium by ramoplanin at concentrations close to the MIC resulted in the accumulation of N-acetylhexosamine-containing nucleotides identified as UDP-MurNAc-pentapeptide. This finding indicates that none of the cytoplasmic enzymes involved in peptidoglycan biosynthesis are the primary target sites for ramoplanin, in contrast to daptomycin (2) .
Although ramoplanin is a lipoglycopeptide, its structure is very different from those of daptomycin (a lipopeptide) and the glycopeptide antibiotics (vancomycin and teicoplanin) which bind to terminal D-alanyl-D-alanine residues of the growing peptidoglycan chain (9) , thus preventing the transglycosylation reaction. The results suggest that ramoplanin has a different mechanism of action from that of the glycopeptides. Only relatively small amounts of the antibiotic were bound in contrast to vancomycin, and furthermore, vancomycin had no inhibitory effect on peptidoglycan synthesis when UDP-MurNAc-tetrapeptide was used as a substrate for G. homari, because of the absence of any Cterminal D-alanyl-D-alanine residues (5). In contrast, ramoplanin inhibited peptidoglycan biosynthesis from either UDP-MurNAc-tetrapeptide or UDP-MurNAc-pentapeptide (Table 1) .
The experiments to determine the amount of ramoplanin bound to bacteria were done by bioassay in solution rather than by diffusion in solid media because of the low concentrations of ramoplanin that had to be detected and the limited diffusion of such a large molecule (Mr 2,556) that occurred in agar. Accuracy was maximized by using concentrations of ramoplanin no greater than 20% different from each other in the assay and by using the highly susceptible B. megaterium in the growth rate assays. The amount of ramoplanin removed from solution (5 x 104 molecules per cell) is intermediate between that of a ,B-lactam (2 x 103 to 4 x 103 molecules per cell), which binds covalently to specific enzyme targets, and that of a glycopeptide (1 x 107 molecules per cell). Neither of these two groups of antibiotics pene-trates into bacteria, and the size and polarity of ramoplanin suggest that it is also unlikely to penetrate the cytoplasmic membrane easily, unless a specific transport system exists. However, this has not been definitively established; such experiments await the availability of radiolabeled ramoplanin.
It is evident from the results obtained with particulate preparations of B. megaterium that ramoplanin inhibits the incorporation of wall precursors into polymerized nascent peptidoglycan and that the first reaction to be inhibited is the N-acetylglucosaminyltransferase which catalyzes the addition of GlcNAc to lipid intermediate I. There was no effect, even at high concentrations, on the preceding membranebound reaction, the formation of lipid intermediate I itself. The inhibitory effects of ramoplanin are clearly distinguishable from those of tunicamycin (23) , vancomycin (8, 25) , moenomycin (8), p-lactam antibiotics, and bacitracin (21) which affect other membrane-bound reactions of peptidoglycan synthesis. The degree of inhibition by ramoplanin was highly concentration dependent; at 30 p,g/ml, incorporation into lipid intermediate II and into peptidoglycan was inhibited by 70%. High concentrations of vancomycin (19) and bacitracin (19) were also required to inhibit in vitro systems substantially, and these antibiotics bind to substrate molecules rather than to enzymes (peptides ending in acyl-D-aa [amino acid]-D-aa and undecaprenyl PPi, respectively). At these high concentrations (30 to 100 ,ug/ml), significant effects on the membrane are apparent with both these compounds (17, 19) , but the primary effect on wall biosynthesis is acknowledged because membrane perturbation does not occur at concentrations close to the MIC, whereas the consequences of inhibition of wall synthesis are apparent at this concentration (e.g., the accumulation of wail precursors). The same argument can be applied to ramoplanin: the effects of the antibiotic on a number of membrane functions are observable only at concentrations greater than 10 times the MIC, whereas wall synthesis is inhibited at the MIC. Ramoplanin appears to act after the formation of lipid intermediate I and before transpeptidation links the nascent peptidoglycan to the existing wall. Of the remaining two reactions, the first to be inhibited is the N-acetylglucosaminyltransferase reaction, the same stage that is claimed to be inhibited by nisin (14 The effects of high and low concentrations of ramoplanin on general membrane disorganization in S. aureus confirmed that the primary target site was peptidoglycan biosynthesis and not the membrane. Although leakage of potassium and UV-absorbing material occurred with high concentrations of antibiotic (Fig. 4) , no perturbation of the membrane was apparent at the MIC for this organism (1 ,ug/ml). In addition, the present study showed that low concentrations of ramoplanin had no effects on the functioning of the phosphotransferase system. High concentrations were required to observe effects comparable to those caused by gramicidin S, a known membrane disorganizer, even though in these studies a low concentration of bacteria was used. It appears likely that the binding of the antibiotic molecule to the membrane could account for any detrimental effect of ramoplanin on membrane function (cf. daptomycin [2] ).
Although one cannot exclude the possibility that ramoplanin affects membrane-associated enzymes nonspecifically in the in vitro systems, it is significant that the first membranebound enzyme in peptidoglycan synthesis is not inhibited even at high concentrations of ramoplanin. Furthermore, preliminary studies suggest that ramoplanin probably binds to the first lipid intermediate I, which would explain the requirement for high concentrations before inhibition was obtained.
